[ad_1]
Medical schemes, including Discovery, are desperate to launch low-cost medical aid products, but the Financial Mail has reported that the regulator is, bizarrely, fighting these plans in court.
Financial Mail editor Rob Rose joins Business Day TV to unpack these low-cost health products and the regulator’s position on what he calls ‘an innovation with little apparent downside.’
[ad_2]
Source link